The FDA just Approved Gene Therapy For Blindness

Gene Therapy For Blindness

The Food and Drug Administration (FDA) approved the First Gene Therapy For Blindness in the US on Tuesday-Luxturna of Spark Therapeutics, which treats a form of hereditary vision loss that can lead to blindness. Researchers have been working for decades to change or replace defective genes with healthy genes to treat, cure or prevent disease … Read moreThe FDA just Approved Gene Therapy For Blindness